Pure Protein L.L.C. Appoints Dr. Rico Buchli as Chief Scientist

OKLAHOMA CITY, Okla., Sept. 17, 2024 (SEND2PRESS NEWSWIRE) — Pure Protein L.L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will lead scientific initiatives and oversee the expansion of the company’s immunological products and services portfolio. This strategic move underscores Pure Protein’s commitment to providing innovative, high-quality reagents to the global research and diagnostics community.

Spodak Dental Group Welcomes Dr. Tiffany Dudley as Partner After 15 Years of Dedication and Excellence

DELRAY BEACH, Fla., Sept. 17, 2024 (SEND2PRESS NEWSWIRE) — Spodak Dental Group is thrilled to announce that Dr. Tiffany Dudley has joined the practice as a partner, following 15 years of outstanding service and commitment to patient care. Dr. Dudley’s journey with Spodak Dental Group has been marked by her unwavering dedication to excellence, making this new partnership a natural and exciting progression.

California Legislature Approves Landmark IVF Bill to Require Insurance Coverage for Fertility Healthcare, Sending Measure to Governor Newsom

SACRAMENTO, Calif., Aug. 29, 2024 (SEND2PRESS NEWSWIRE) — The California State Legislature approved Senate Bill 729, authored by State Senator Caroline Menjivar (D-San Fernando Valley) and sponsored by California State Insurance Commissioner Ricardo Lara, with bipartisan support today sending the measure to Governor Newsom’s desk with votes of 55-0 in the Assembly and 30-8 in the Senate.

John Reitano, MD, Uses Connectomics To Personalize Transcranial Magnetic Stimulation (TMS) Treatment At Delve Psychiatry

LAS VEGAS, Nev., Aug. 28, 2024 (SEND2PRESS NEWSWIRE) — As medical science advances, researchers gain a better understanding of how the human body works. The brain is no exception, and a relatively new field of connectomics now analyzes how neurons network with one another within the brain. Board-certified psychiatrist John Reitano, MD, applies this growing body of knowledge to help people with major depressive, anxiety, attention-deficit / hyperactivity (ADHD) and obsessive-compulsive (OCD) disorders and other conditions at Delve Psychiatry in Las Vegas.

Ke Kino Institute of Healing Launches Innovative Bodywork for Babies Massage Therapy Program

DALLAS, Texas, Aug. 13, 2024 (SEND2PRESS NEWSWIRE) — Ke Kino Institute of Healing is proud to announce our Bodywork for Babies massage therapy program in Dallas. Where we combine multiple modalities, specialties and decades of practice to bring you targeted care with a holistic approach. Focusing entirely on the well-being of both mothers and their babies, treating them as the unit that they are.

Lutheran Home’s ‘Best Friend’s Guide to Dementia’ Series Kicks Off

ARLINGTON HEIGHTS, Ill., Aug. 7, 2024 (SEND2PRESS NEWSWIRE) — Lutheran Home is hosting a complimentary “Best Friends Guide to Dementia” educational series starting this month. The healthcare campus is part of non-profit Lutheran Life Communities and provides the most comprehensive constellation of memory support services, options and resources in Arlington Heights.

NPA Announces New Cohort of IMPACT Fellows: Six remarkable postdocs hailing from underrepresented communities form fourth IMPACT class

BETHESDA, Md., Aug. 7, 2024 (SEND2PRESS NEWSWIRE) — The National Postdoctoral Association (NPA) today announced the members of its fourth class of scholars in its signature program designed to advance diversity, equity, inclusion, and belonging in the postdoctoral community and beyond. The six fellows in the NPA’s 2024-2025 IMPACT Fellowship Program (“IMPACT”) are postdoctoral researchers representing diverse backgrounds, disciplines, and geographies.

SET Enterprises launches 340b covered entity suspicious purchase identification service for pharmaceutical and biological manufacturers

PHOENIX, Ariz., Aug. 2, 2024 (SEND2PRESS NEWSWIRE) — SET Enterprises, a leading independent management consulting firm serving the government pricing compliance needs of life sciences manufacturers, today announced the launch of SPI340B℠. This new service offering identifies specific 340B covered entities that exhibit suspicious purchasing patterns that suggest the entire volume of products purchased from pharmaceutical and biotechnology manufacturers may not be dispensed solely to eligible patients of the covered entity.

Personal Practitioners AZ Announces Use of Objective ADHD Testing Technology for Diagnosis and Treatment

SCOTTSDALE, Ariz., July 26, 2024 (SEND2PRESS NEWSWIRE) — Personal Practitioners today announces its adoption of QbTest, an objective ADHD test providing clinicians with measurable data for unbiased decision-making and support. The test, created by the global leader in ADHD testing, Qbtech, is the first FDA-cleared solution to aid clinicians when diagnosing and treating ADHD in children, adolescents, and adults.